Walgreens acquires rights to Theragran-M multivitamins
Theragran-M Advanced formula will return exclusively to Walgreens stores in mid-October. The multivitamin was one of the most widely used supplements and one of Walgreens best selling brands.
Theragran-M Advanced formula will return exclusively to Walgreens stores in mid-October. The multivitamin was one of the most widely used supplements and one of Walgreens best selling brands.
Of the eight patients who have completed treatment in the study, two experienced grade IV acute graft-versus-host-disease, or aGVHD, a known potential side effect in transplantation. Both patients
The decision is thought to represent a severe blow to GSK’s efforts to become the first company to bring to market a CCR5 inhibitor, a new type of
Results of the study of 17 subjects with moderate to severe acne indicated that 16 of 17 subjects (94%) experienced a reduction in total acne lesion count of
The company now hopes to further establish the potential of Proxinium in a clinical trial involving 10 sites across North America. “While there are limited treatment options for
Batten disease is a rare and fatal neuro-degenerative genetic condition affecting infants and children. The proposed phase I trial has been on hold since February 2005, pending a
Vaccinia Immune Globulin is a hyperimmune product to be used in treating and preventing a type of severe reaction that may be brought on by administration of the
The compounds were identified by Dr Charles Sawyers at the University of California, Los Angeles. Medivation intends to begin clinical development with these compounds by the end of
The ability of the HIV virus to establish resistance to therapeutic drugs through genetic mutation is a major concern in the treatment of HIV/AIDS. With the increasing number
Remicade is now indicated for reducing signs and symptoms, achieving clinical remission and mucosal healing, and eliminating corticosteroid use in patients with moderately to severely active ulcerative colitis